Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase-Reference-Cited by-同舟云学术

Gallium Maltolate Disrupts Tumor Iron Metabolism and Retards the Growth of Glioblastoma by Inhibiting Mitochondrial Function and Ribonucleotide Reductase

Published:2018-03-28 Issue:6 Volume:17 Page:1240-1250
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Chitambar Christopher R.,Al-Gizawiy Mona M.,Alhajala Hisham S.,Pechman Kimberly R.,Wereley Janine P.,Wujek Robert,Clark Paul A.,Kuo John S.,Antholine William E.,Schmainda Kathleen M.

Funder

Rosenberg Foundation and Medical College of Wisconsin Cancer Center

HHS | NIH | National Cancer Institute (NCI)

HHS | National Institutes of Health (NIH)

Advancing Healthier Wisconsin Research Program

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations;International Journal of Biological Macromolecules;2024-10

2. A Ubiquitin‐Competitive Strategy Based on the Element Microenvironment to Treat Osteoarthritis;Advanced Functional Materials;2024-08-06

3. In Silico Analysis of the Ga3+/Fe3+ Competition for Binding the Iron-Scavenging Siderophores of P. aeruginosa—Implementation of Three Gallium-Based Complexes in the “Trojan Horse” Antibacterial Strategy;Biomolecules;2024-04-16

4. Liquid metals enabled advanced cryobiology: development and perspectives;Soft Science;2024-01-17

5. Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma;Frontiers in Oncology;2024-01-15